Repercussions of the Karonga prevention trial for tuberculosis control.
Rieder
H L
HL
International Union Against Tuberculosis and Lung Disease, Paris, France.
D001500:BCG Vaccine / Q000009:adverse effects*; D015658:HIV Infections / Q000150:complications; D006801:Humans; D008295:Malawi; D014397:Tuberculosis, Pulmonary / Q000517:prevention & control*; D014611:Vaccination / Q000009:adverse effects
D001500:BCG Vaccine